Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug copy tested in lung cancer patients

NCT ID NCT06268613

Ongoing Disease control Sponsor: Samsung Bioepis Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This study is testing if a new version of the cancer drug pembrolizumab (called SB27) behaves the same way in the body as two existing versions. It involves patients with early-stage lung cancer who have already had surgery and chemotherapy. The main goal is to compare how much drug stays in the blood over time between the three versions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE II are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • SB Investigative Site

    Gdansk, Poland

  • SB Investigative Site

    Otwock, Poland

  • SB Investigative Site

    Ansan, South Korea

  • SB Investigative Site

    Busan, South Korea

  • SB Investigative Site

    Daegu, South Korea

  • SB Investigative Site

    Hwasun, South Korea

  • SB Investigative Site

    Incheon, South Korea

  • SB Investigative Site

    Jinju, South Korea

  • SB Investigative Site

    Seongnam, South Korea

  • SB Investigative Site

    Ulsan, South Korea

  • SB Investigative Site

    A Coruña, Santiago de Compostela, Spain

  • SB Investigative Site

    Jaén, Spain

  • SB Investigative Site

    Málaga, Spain

  • SB Investigative Site

    Adana, Turkey (Türkiye)

  • SB Investigative Site

    Istanbul, Turkey (Türkiye)

  • SB Investigative Site

    Izmir, Turkey (Türkiye)

  • SB Investigative Site 1

    Suwon, South Korea

  • SB Investigative Site 1

    Ankara, Turkey (Türkiye)

  • SB Investigative Site 2

    Suwon, South Korea

  • SB Investigative Site 2

    Ankara, Turkey (Türkiye)

  • SB Investigative Site 3

    Seoul, South Korea

  • SB Investigative Site 4

    Seoul, South Korea

  • SB Investigative Site 5

    Seoul, South Korea

  • SB Investigative Site 6

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER STAGE II NON-SMALL CELL LUNG CANCER STAGE IIIA